• Tanuj Soni
• Pradeep Kumar Yadav
• Akhlesh Kumar Singhai

Vaginal drug delivery systems offer a promising avenue for the treatment and prevention of sexually transmitted diseases (STDs). This paper explores the potential of vaginal drug delivery in the context of STD management, focusing on its advantages, challenges, and current developments. The unique anatomical and physiological characteristics of the vaginal mucosa make it an ideal site for drug delivery, allowing for localized treatment with reduced systemic side effects. Various drug delivery systems, including gels, creams, suppositories, and vaginal rings, are discussed, highlighting their mechanisms of action and potential applications in STD treatment. Additionally, considerations such as patient acceptability, adherence, and safety are addressed. Furthermore, emerging technologies and innovative approaches in vaginal drug delivery for STDs are explored, offering insights into future directions for research and development in this field. Overall, vaginal drug delivery systems hold great promise for improving the efficacy and accessibility of STD treatment and prevention strategies, potentially revolutionizing the landscape of sexual health care.

Public Health, STD, Vaginal Drug Delivery, Implantable devices, Estring, Femring, NuvaRing, Mucoadhesive

"VAGINAL DRUG DELIVERY SYSTEMS AND TREATMENT OF STDs", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.11, Issue 4, page no.m621-m636, April-2024, Available :http://www.jetir.org/papers/JETIR2404C81.pdf

"VAGINAL DRUG DELIVERY SYSTEMS AND TREATMENT OF STDs", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.11, Issue 4, page no. ppm621-m636, April-2024, Available at : http://www.jetir.org/papers/JETIR2404C81.pdf